normal phenotype
|
• viable and fertile despite having only approximately 12% of normal levels of ECHS1 in heart, liver, and brain
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Echs1em1Lutzy endonuclease-mediated mutation 1, Cathy Lutz MGI:8282681 |
||||||||||||
| Summary |
2 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• viable and fertile despite having only approximately 12% of normal levels of ECHS1 in heart, liver, and brain
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• A third of compound heterozygotes die after being injected with a dose of LPS that 100% of wildtype controls survive, and the surviving mutants have delayed weight recovery and failure to thrive
|
|
• increased active awake state, normal awake inactive state, and decreased slow wave sleep
|
|
• although no differences are found in sensory gating during pre-pulse inhibition using auditory stimuli, there is increased latency to withdraw the foot from the hotplate
|
|
• Although spontaneous seizures are not observed, compound heterozygotes have increased pentylenetetrazol-induced seizure numbers and severity and this in increased with a 3% increase in dietary valine
|
|
• normal brain development and no degeneration seen at 18 months of age compared with wildtype, but twice as many microglia are found in the striatum
|
|
• exercise fatigue with elevated post-exercise lactate levels, and abnormal levels of various amino acids, both branched-chain and non-branched chain, in the liver at 3 months
|
|
• Although spontaneous seizures are not observed, compound heterozygotes have increased pentylenetetrazol-induced seizure numbers and severity and this in increased with a 3% increase in dietary valine
|
|
• normal brain development and no degeneration seen at 18 months of age compared with wildtype, but twice as many microglia are found in the striatum
|
|
• normal brain development and no degeneration seen at 18 months of age compared with wildtype, but twice as many microglia are found in the striatum
|
|
• increased as measured by EEG at approximately 3.5 month of age
|
|
• increased as measured by EEG at approximately 3.5 month of age
|
|
• normal brain development and no degeneration seen at 18 months of age compared with wildtype, but twice as many microglia are found in the striatum
|
|
• Assessment of liver amino acid content at 3 months of age found only a slight elevation in branched chain amino acids, but a significant elevation in approximately 60% of non-branched chain amino acids
|
|
• no differences in anxiety or fear conditioning, but compound heterozygotes display a progressive reduction in latency to fall from a rotarod by the eighth trial, attributed to exercise fatigue, with shortened run distance and higher than normal post-exercise lactate levels
|
|
• A third of compound heterozygotes die after being injected with a dose of LPS that 100% of wildtype controls survive, and the surviving mutants have delayed weight recovery and failure to thrive
|
|
• normal brain development and no degeneration seen at 18 months of age compared with wildtype, but twice as many microglia are found in the striatum
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| mitochondrial short-chain enoyl-CoA hydratase 1 deficiency | DOID:0070540 |
OMIM:616277 |
J:378496 | |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/28/2026 MGI 6.24 |
|
|
|
||


